ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study

NCT03082690 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

HIV Prevention

Interventions

DRUG: DuoGel

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]